Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Yun Hui Sheryl WONG

Yun Hui Sheryl WONG

Doctor
Royal Perth Hospita
Australia

Biography

Dr Yun Hui Sheryl Wong is currently a renal advanced trainee in Western Australia and is interested in the area of dialysis and chronic kidney disease. Ms Ann Berwick is currently a clinical pharmacist at Royal Perth Hospital. Ms Anne Ngyuen is currently a clinical pharmacist at Royal Perth Hospital Ms Kate Morley is a clinical dietician who works out from Amity Health. Prof Mark Thomas is a nephrologist at Royal Perth hospital and has been involved in more than 20 publications.

Research Interest

As chronic kidney disease progresses through the 5 stages, hyperphosphataemia occurs, resulting in bone demineralisation, vascular and soft tissue calcification, cardiovascular disease and secondary hyperparathyroidism. Dietary restriction of phosphate alone becomes insufficient over time to counteract this process and various phosphate binders are commonly prescribed to reduce the absorption of phosphate from the gastrointestinal tract. Magnesium based phosphate binders have been shown to be non-inferior to sevelamer for the management of hyper-phosphataemia. However, there is a vast array of commercial magnesiumbased supplements available to the Australian consumer. Considerable heterogeneity exists not only in their magnesium content, but the concentration of other additional ions like calcium, potassium and phosphate. We discuss these supplements and present them in a table. The clinician should note that caution should be exercised when prescribing these supplements, particularly to the CKD population.(137 words)